Please provide your email address to receive an email when new articles are posted on . CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated in patients with more than 8 days of ...
ANN ARBOR, Mich., April 12, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
LONG BEACH, Calif. -- Methotrexate, during and after surgery for primary retinal detachment, has produced "amazing" early results in preventing proliferative vitreoretinopathy (PVR), according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results